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        Introduction 
  The Raf kinases (A-Raf, B-Raf, and Raf-1) relay extracellu-
lar signals to the MAPK/extracellular signal-regulated kinase 
(ERK) kinase (MEK)/ERK signaling module. Among the three 
Raf kinases, B-Raf binds best to MEK and has the highest basal 
MEK kinase activity. Growth factor  –  stimulated ERK activa-
tion is reduced (    60%) in cells lacking B-Raf but not in 
A-Raf –   or  Raf-1 – defi  cient cells (  Wojnowski et al., 2000  ;   Huser 
et al., 2001  ;   Mikula et al., 2001  ;   Mercer et al., 2002  ;   Pritchard 
et al., 2004  ). Finally, Raf kinases from lower organisms (  lin-45  
in   Caenorhabditis elegans   and   D-Raf   in   Drosophila melano-
gaster  ) are more similar to B-Raf than to A-Raf or Raf-1 
(  Wellbrock et al., 2004  ). All these observations hint at B-Raf 
as the essential mammalian MEK kinase, whereas A-Raf and 
Raf-1 may have a subordinate role or have diverged to perform 
other functions. 
  B-Raf is mutated in a high percentage of certain human 
cancers (  Davies et al., 2002  ) and congenital progressing condi-
tions like cardio-facio-cutaneous syndrome (  Rodriguez-Viciana 
et al., 2006  ). This discovery has generated huge industrial inter-
ests and inhibitors are currently being tested in preclinical and 
clinical trials. However, our fundamental understanding of 
B-Raf biology is still scanty, and embryonic lethality associ-
ated with germline B-Raf ablation (  Wojnowski et al., 1997  ; 
  Galabova-Kovacs et al., 2006  ) has precluded its investigation. 
B-Raf is highly expressed in cells of neuronal origin ( Wojnowski 
et al., 2000  ) and reportedly plays a prosurvival role in cultured 
primary embryonic neurons (  Wiese et al., 2001  ). Therefore, the 
analysis of animals in which B-Raf is selectively ablated in neu-
ronal cells is of particularly interest. Indeed, conditional abla-
tion in forebrain excitatory neurons has shown an essential role 
for B-Raf in hippocampus-dependent learning (  Chen et al., 2006  ). 
The more generalized ablation of   b-raf   in neuronal precursors 
leads to growth retardation, disorders of hypothalamic-pituitary 
function, and premature death.   b-raf   ablation does not interfere 
with neurogenesis or neuron survival, and the only molecular 
defect investigated to date is the reduced expression of the glial 
cell line  –  derived neurotrophic factor receptor Ret in dorsal root 
M
utations in the extracellular signal-regulated ki-
nase (ERK) pathway, particularly in the mitogen-
activated protein kinase/ERK kinase (MEK) 
activator B-Raf, are associated with human tumorigenesis 
and genetic disorders. Hence, B-Raf is a prime target for 
molecule-based therapies, and understanding its essential 
biological functions is crucial for their success. B-Raf is ex-
pressed preferentially in cells of neuronal origin. Here, we 
show that in mice, conditional ablation of B-Raf in neuro-
nal precursors leads to severe dysmyelination, defective 
oligodendrocyte differentiation, and reduced ERK activa-
tion in brain. Both B-Raf ablation and chemical inhibition 
of MEK impair oligodendrocyte differentiation in vitro. 
In glial cell cultures, we ﬁ  nd B-Raf in a complex with MEK, 
Raf-1, and kinase suppressor of Ras. In B-Raf  –  deﬁ  cient 
cells, more Raf-1 is recruited to MEK, yet MEK/ERK phos-
phorylation is impaired. These data deﬁ  ne B-Raf as the 
rate-limiting MEK/ERK activator in oligodendrocyte dif-
ferentiation and myelination and have implications for the 
design and use of Raf inhibitors.
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content/full/jcb.200709069/DC1). Spleen size was markedly de-
creased (unpublished data), likely because of the previously re-
ported essential role of B-Raf in B cell development (  Brummer 
et al., 2002  ). With the exception of the latter, all phenotypes were 
phenocopied in   NestinCre ; b-raf  
f/f     ( b-raf  
   /  neu    ) animals, which ex-
press the Cre recombinase in CNS neural precursor cells that give 
rise to both neurons and glia (  Tronche et al., 1999  ;   Haigh et al., 
2003  ). NestinCre mediated effi  cient recombination in brain and 
spinal cord as early as embryonic day 11.5 (Fig. S1). Complete 
conversion of the   b-raf  
f     to the   b-raf  
        allele was evident in brain 
and spinal cord (not depicted) but not in other tissues derived 
from   b-raf  
   /  neu     mice (  Fig. 1 B  ). Accordingly, B-Raf could not be 
detected by immunoblotting in   b-raf  
   /  neu     brain (  Fig. 1, C and D  ), 
spinal cord (  Fig. 1 D  ), and glial cell cultures derived from P0 ani-
mals (see Fig. 6, A  –  C). In B-Raf  –  defi  cient brains, A-Raf ex-
pression was unchanged, whereas Raf-1 was slightly up-regulated 
( Fig. 1 D ). Thus, the pathology (growth retardation, muscle weak-
ness, tremors, and ataxia) observed in   Mox2 
cre/+ ;b-raf  
f/f     was 
caused by a defect of neural precursor cells. Histological exami-
nation revealed severe atrophy of skeletal muscle fi  bers (Fig. S2 C) 
but axon retraction/degeneration was not detected, and both the 
morphology and innervation of the neuromuscular junctions were 
normal in the   b-raf  
   /  neu     mice (Fig. S2 D). 
  Macroscopically and histologically, the brains of   Mox2 
cre/+ ;
b-raf  
f/f    and  b-raf  
   /  neu    did not show gross anomalies. P18 B-Raf – 
defi  cient brains were slightly smaller than those of WT littermates 
and the molecular layer of their brain cortex was thinner (Fig. S2, 
A and B;   Zhong et al., 2007  ). In the cerebellum, B-Raf ablation 
caused a slight accumulation of granular cells at the cerebellar 
surface, which could be caused by a delay in postnatal   migration 
or a mild increase in precursor proliferation (Fig. S3, available at 
http://www.jcb.org/cgi/content/full/jcb.200709069/DC1). These 
defects were observed with a 100% penetrance. 
  Ablation of B-Raf in neuronal precursors 
causes CNS dysmyelination 
  The mild anomaly in cerebellar development may contribute 
to the ataxic behavior of the   b-raf  
   /  neu     mice (  Grusser-Cornehls 
ganglion neurons at postnatal stages, a rather mild phenotype. 
Concomitant elimination of   b-raf   and   c-raf-1   strongly  reduced 
axon growth in vitro and cutaneous axon terminal arborization 
in vivo, which suggests that Raf-1 can compensate for the loss 
of B-Raf function in this sytem (  Zhong et al., 2007  ). 
 We show that mice with epiblast-restricted ( Mox2 
cre/+ ;b-raf  
f/f   ) 
and neuronal precursor  –  restricted   b-raf   ablation (  b-raf 
   /  neu   ) 
develop progressive loss of coordination, tremors, and severe 
muscular weakness and die around postnatal day 21 (P21). 
In line with this phenotype, we detect a major defect in central 
nervous system (CNS) myelination and reduced oligodendro-
cyte differentiation. B-Raf knockout (KO) oligodendrocytes in 
situ and in culture fail to activate MEK/ERK and to differentiate, 
despite the increased recruitment of Raf-1 to MEK in KO cells. 
Blunting ERK activation in wild-type (WT) oligodendrocytes with 
a MEK inhibitor similarly impairs differentiation. Together, the 
data indicate an essential role of B-Raf and its downstream ef-
fector ERK in oligodendrocyte differentiation and myelination. 
  Results 
  Ablation of B-Raf in the epiblast and in 
neuronal precursors causes severe 
neuromuscular defects 
  b-raf   was inactivated by Cre-  loxP    –  mediated deletion of exon 11, 
which encodes the kinase domain (  Chen et al., 2006  ). Deletion 
leads to a shift in the open reading frame and completely abrogates 
B-Raf protein expression (  Fig. 1, C  –  D  ).    Epiblast-restricted abla-
tion in the 129/Sv background yielded live offspring.   Mox2 
cre/+ ;
b-raf  
f/f    were indistinguishable from littermate controls at birth but 
showed growth retardation starting around P10. This phenotype 
was followed by loss of coordination, the onset of tremors, ataxia, 
and muscle weakness (at P15). P10  –  21, B-Raf  –  defi  cient animals 
suspended by the tail clasped their limbs to their trunks in a 
dystonic fashion, a diagnostic sign of neurological impairment 
(  Fig. 1 A  ). After P18, the   Mox2 
cre/+ ;b-raf   
f/f     mice deteriorated 
rapidly, showing increasing diffi  culties in ambulating and fi  nally 
in breathing (Videos 1  –  3, available at http://www.jcb.org/cgi/
  Figure 1.       Neurological defects and growth 
retardation in B-Raf  –  deﬁ  cient  mice.   (A) Limb 
clasping reﬂ   ex in P18   Mox2 
cre/+  ;b-raf   
f/f     and 
  b-raf  
  Δ  /  Δ  neu     mice suspended by the tail. (B) 
Complete conversion of the   b-raf   
f/f     to   b-raf 
   Δ /  Δ      
alleles in brain but not in other tissues of P18 
  b-raf  
  Δ  /  Δ  neu     mice. PCR analysis of: T, tail; B, 
brain; Liv, liver; L, lung; Sp, spleen; Th, thy-
mus; H, heart; and K, kidney. N, negative 
control (H  2  O); f/      and +/+, positive controls. 
(C) Immunoblots of brain lysates from P18   b-raf  
f/f     
(WT) and   b-raf  
  Δ  /  Δ  neu     (KO) mice probed with 
antibodies against N- or C-terminal B-Raf ep-
itopes demonstrate the complete absence of 
B-Raf protein. The position of the molecular 
weight markers is shown between the auto-
radiograms. The arrow indicates B-Raf. Actin 
immunoblot, loading control. (D) Immunoblot of 
brain and spinal cord lysates from P18   b-raf   
f/f     
(WT) and   b-raf  
  Δ  /  Δ  neu     (KO) mice. MEK2 immuno-
blot, loading control.     949 B-RAF AND MYELINATION   •   GALABOVA-KOVACS ET AL.
  Oligodendrocytes are the myelin-forming macroglia of the 
vertebrate CNS. They originate mostly from ventral but also dor-
sal sources in the spinal cord and forebrain (  Richardson et al., 
2006  ). Oligodendrocyte precursors with proliferative capacity 
express the NG2 proteoglycan and PDGF receptor       (PDGFR   ) 
and migrate from their sites of origin to their fi  nal position in the 
white matter, where terminal differentiation starts at the end of 
embryogenesis. Terminal differentiation is characterized by loss 
of NG2 and PDGFR     , the up-regulation of the cytoskeletal 
marker    IV-tubulin (expressed by premyelinating, early myelina-
ting, and myelinating oligodendrocytes;   Terada et al., 2005  ), and 
the induction of myelin genes like MBP. At P18, B-Raf  –  defi  cient 
brains contained more undifferentiated PDGFR    +  oligodendro-
cytes than WT brains in all regions investigated (  Fig. 4 A   and 
Fig. S5, C and D).    In parallel, the amount of     IV-tubulin+  cells 
was reduced. Together with the reduced expression of MBP and 
the dysmyelination observed in B-Raf KO CNS, this suggested 
that B-Raf ablation caused a delay in oligodendrocyte differentia-
tion. To confi  rm this, we established oligodendrocyte precursor 
cultures (  Zezula et al., 2001  ) from WT and B-Raf KO brains. The 
initial purity (88   ±   12% NG2+ cells) and the total number of cells 
present in these cultures were comparable. After differentiation, 
however, B-Raf KO cultures contained signifi  cantly higher num-
bers of NG2+ prooligodendrocytes, whereas the amount of pre-
myelinating oligodendrocytes (NG2+/O4+ with radial processes 
and limited arborization, and O4+ cells with a complex process 
network) was correspondingly decreased (  Fig. 4 B  ). MBP+ cells 
were hardly present in B-Raf  –  defi  cient cultures and the few 
detected expressed much less MBP than WT cells (  Fig. 4 C  ). WT 
oligo  dendrocyte precursor cultures differentiating in the presence 
of the MEK inhibitor U0126 also failed to produce MBP+ cells 
(  Fig. 4 C  ). This shows a causal link between ERK phosphoryla-
tion and oligodendrocyte differentiation and suggests that B-Raf 
is required for effi  cient ERK phosphorylation in this system. 
and Baurle, 2001  ). Overall, however, the neurological symp-
toms of the   b-raf  
   /  neu     mice and their onset on P14 are reminis-
cent of those observed in myelin mutants occurring naturally, 
like   shiverer   or   jimpy   ( Sturrock,  1980 ;   Popko  et  al.,  1987 ;   Nave, 
1994  ), or generated by gene targeting (  Olig1   null mice;   Xin 
et al., 2005  ), which suggests a defect in myelination. Indeed, at 
P18, signifi  cantly fewer myelinated fi  bers could be observed in 
different areas of P18   b-raf  
   /  neu     brains  ( Fig.  2, A – C ;  Fig.  S4 A; 
and Fig. S5, A and B, available at http://www.jcb.org/cgi/content/
full/jcb.200709069/DC1), and immunoblotting confi  rmed a 
reduction in the total amount of myelin basic protein (MBP; 
  Figs. 2 D   and S4, B and C).    In the spinal cord and peripheral 
nerves, MBP staining was very strong and the differences be-
tween WT and   b-raf  
   /  neu     were not as clear (unpublished data). 
Immunohistochemical analysis and quantitative immunoblotting 
of P0  –  18 brains showed that myelination was reduced signifi  -
cantly in   b-raf  
   /  neu     animals throughout postnatal development 
(Fig. S4 D). The decrease in MBP expression was also evident 
at the mRNA level (Fig. S4 E). In contrast to MBP, the expres-
sion of other major myelin components (MAG, MOG, and PLP/
DM20) was unchanged. Transmission electron microscopy of 
selected CNS areas showed that B-Raf ablation did not prevent 
axon recognition and ensheathment; however, the number of 
unmyelinated fi  bers in the optic nerve, corpus callosum, and, 
less obviously, in the spinal cord (  Fig. 3   and not depicted) of 
  b-raf  
   /  neu    mice was clearly increased.    In addition, the g ratio (the 
numerical ratio between the diameter of the axon proper and the 
outer diameter of the myelinated fi  ber) was higher than in WT 
CNS. Signs of gliosis were observed in the optic nerve but we 
did not observe axonal swelling or degeneration, fragmented 
organelles, myelin debris, or macrophage infi  ltration. In addi-
tion, the total number of axons in WT and   b-raf  
   /  neu     optic  nerves 
did not differ. All these data are consistent with a delay in CNS 
myelination (dysmyelination) rather than with demyelination. 
  Figure 2.         b-raf   ablation in neuronal precursors leads to hypomyelination of the brain.   (A  –  C) Hypomyelination of different regions of the P18   b-raf 
  Δ  /  Δ  neu     
brain revealed by immunohistochemistry (IHC) using an      -MBP antibody on parafﬁ  n sections. Brown staining indicates MBP+ ﬁ  bers and cells. The sections 
were counterstained with hematoxylin. (A) Brain cortex. (B) Detail of the cortex. (C) Hippocampus and the dentate gyrus (arrows). (D) MBP expression 
determined by immunoblotting of brain lysates. The reduced MBP expression in the   b-raf 
  Δ  /  Δ  neu     lysates correlates with the results obtained in the IHC.     JCB • VOLUME 180 • NUMBER 5 • 2008  950
  At P18, ERK phosphorylation was readily detectable by 
immunohistochemistry in various areas of the WT brain, includ-
ing cortex, cerebellum, and hypothalamus (  Fig. 5 B   and not de-
picted). In particular, a strong positive signal was observed in 
the neuropil of the forebrain and cerebellar cortical plate, which 
consists of axons, dendrites and glial processes, and in the Purkinje 
cells of the cerebellar cortex. In the forebrain cortex, the pERK 
signal was more rarely associated with cell bodies, and if it was, 
it was mainly observed in cells featuring the small heterochro-
matic nuclei typical of glial cells. pERK was dramatically re-
duced in all cells and areas of   b-raf  
   /  neu     brains (  Fig. 5 B  ). 
  B-Raf is required for MEK/ERK activation 
in oligodendrocyte-enriched cultures and in 
oligodendrocytes in vivo 
  To assess whether B-Raf was required for MEK/ERK activa-
tion in cells of the oligodendrocytic lineage, we stimulated 
  oligodendrocyte-enriched primary mixed glial cultures with 
PDGF, which reportedly regulates oligodendrocyte develop-
ment (  Fruttiger et al., 1999  ) and activates ERK in differentiating 
oligodendrocytes (  Bhat and Zhang, 1996  ). PDGF-induced 
phosphorylation of MEK and ERK was impaired in the B-Raf  –
 defi  cient cells (  Fig. 6 A  ).    In contrast, B-Raf ablation had hardly 
any effect on basal and PDGF-induced MEK/ERK phosphory  la-
tion in oligodendrocyte-depleted glial cell cultures (  ≥  90% astro-
cytes;   Fig. 6 B  ), which supports the idea that oligodendrocytes 
are the glial cell type in which ERK phosphorylation is most 
affected by the lack of B-Raf. A decrease in MEK/ERK phos-
phory  lation was also apparent in B-Raf  –  defi  cient, oligodendrocyte-
enriched cultures treated with other stimuli involved in 
oligodendrocyte differentiation, namely FGF (  Kessaris et al., 
  Molecular correlates of B-Raf ablation in 
the brain 
  We next determined the expression of the Raf kinases and the 
activation status of their downstream targets MEK/ERK during 
postnatal brain development (  Fig. 5 A  ).    A-Raf and MEK2 
were stably expressed in both WT and B-Raf  –  defi  cient brains. 
In contrast, B-Raf and MEK1 were expressed at low levels in 
newborn brains and increased steadily thereafter. Raf-1 showed 
an opposite pattern, being expressed at higher levels in P0 and 
P5 animals and decreasing in WT animals older than 10 d. 
Raf-1 expression was slightly up-regulated in P10  –  18 B-Raf  –
 defi  cient brains. ERK phosphorylation paralleled B-Raf/MEK1 
expression, being very low in WT P0  –  5 brains and rising 
steadily from P10 on. B-Raf ablation strongly decreased ERK 
phosphorylation between P10 and 18. In contrast, the kinetics 
and extent of phosphorylation of p38 and JNK were similar in 
WT and KO brains (unpublished data). Lack of ERK phosphory-
lation correlated with a dramatic reduction in the expression of 
EGR1, a downstream target of the ERK cascade (  Harada et al., 
2001  ) expressed in oligodendrocyte progenitors and induced 
upon differentiation (  Fig. 5 A  ;   Sock et al., 1997  ). In addition, 
the B-Raf  –  dependent rise in ERK phosphorylation coincided 
with an increase in      IV-tubulin expression, which is indicative 
of oligodendrocyte maturation (  Terada et al., 2005  ). Consistent 
with a defect in oligodendrocyte maturation, less     IV-tubulin 
was detected in B-Raf KO lysates (  Fig. 5 A  ). Thus, increased 
B-Raf expression and B-Raf  –  dependent ERK phosphorylation 
correlated temporally with the developmental window during 
which myelination of the upper CNS takes place (  Foran and 
  Peterson, 1992  ) and with the onset of the neurological symp-
toms in the   b-raf  
   /  neu     mice. 
  Figure 3.       Hypomyelination in the CNS of 
the of   b-raf 
  Δ  /  Δ  neu     mice.   Electron micrographs 
of P18 optic nerves (A) and spinal cords (B) 
in cross section. Note the high proportion of 
unmyelinated axons (plotted on the right as 
mean   ±   SD for the optic nerve; *, P   <   0.05 
comparing   b-raf  
f/f     and   b-raf  
  Δ  /  Δ  neu     mice) and the 
thinner myelin sheaths in   b-raf  
  Δ  /  Δ  neu     sections. 
The scatter plots show g ratios (diameter of the 
axon proper:outer diameter of the myelinated 
ﬁ  ber) as a function of axon diameter for op-
tic nerve and spinal cord (100 axons/mouse, 
three   b-raf  
f/f    , and three   b-raf 
   Δ /  Δ  neu     mice). White 
symbols indicate WT and gray symbols indi-
cate   b-raf  
  Δ  /  Δ  neu     mice. g ratios are higher in the 
  b-raf   
  Δ  /  Δ  neu     mice (P   <   0.0005), which indicates 
hypomyelination. Bars, 2.5   μ  m.     951 B-RAF AND MYELINATION   •   GALABOVA-KOVACS ET AL.
  Finally, to confi  rm that B-Raf is the ERK activator in dif-
ferentiating oligodendrocytes in vivo, we colabeled P18 brain 
sections with antibodies against pERK and     IV-tubulin.  On  the 
basis of their morphology ( Zhang, 2001 ), pERK+ cells were clas-
sifi  ed as premyelinating oligodendrocytes, featuring processes 
with a low degree of arborization (  Fig. 6 F  , left) or more elabo-
rate process networks (middle); and mature myelinating cells 
extending their processes toward myelin sheets (  Fig. 6 F  , right). 
In the latter case, a very strong pERK signal was associated 
with the myelinated fi  bers. ERK phosphorylation was undetect-
able in      IV-tubulin+ cells from   b-raf  
   /  neu     brains (  Fig. 6 F  ). 
  Discussion 
  Our data allow several important conclusions. The fact that the 
deletion of   b-raf   in neuronal precursors almost completely pheno-
copies the deletion in the embryo proper (with the exception 
of the reduced spleen) implies that in vivo, at least during the 
fi  rst 3 wk of life, B-Raf is not absolutely required for prolifera-
tion, survival, or differentiation of other cell types. As has been 
previously suggested (  Zhong et al., 2007  ), the lack of major 
2004  ;   Oh et al., 2003  ) and EGF (  Fig. 6 C  ;   Aguirre et al., 2007  ). 
Consistent with the decrease in ERK phosphorylation, nuclear 
translocation of ERK was impaired in B-Raf  –  defi  cient oligo-
dendrocytes (  Fig. 6 D  ). 
  To gain more insight into the wiring of the ERK pathway, 
we prepared MEK1 immunoprecipitates from mixed glial cul-
tures and monitored the association of MEK with other ERK 
pathway components (  Fig. 6 E  ). Although, as described previ-
ously ( Kortum and Lewis, 2004 ;  Fujioka et al., 2006 ), the amounts 
of coprecipitating proteins were very low, WT MEK immuno-
precipitates contained kinase suppressor of Ras 1 (KSR1), a 
scaffold protein with high similarity to Raf-1 that can bind to 
all members of the ERK pathway and facilitate signal propaga-
tion (  Morrison, 2001  ;   Nguyen et al., 2002  ), B-Raf, and Raf-1. 
B-Raf ablation decreased the association of the MEK with KSR, 
whereas the amount of coprecipitating Raf-1 was unchanged or 
increased (  Fig. 6 E   and not depicted). Thus, in this oligodendro-
cyte-enriched glial cell population, Raf-1 can bind to MEK1 in 
the absence of B-Raf but cannot take its place as a MEK kinase 
or stimulate MEK  ’  s association with KSR, which ultimately re-
sults in impaired ERK phosphorylation (  Fig. 6, A, C, and D  ). 
  Figure 4.       Oligodendrocytes maturation is defective in   b-raf  
  Δ  /  Δ  neu     mice.   Immature, PDGFR     + oligodendrocytes, stained in brown, are present in several areas 
of the P18   b-raf   
  Δ  /  Δ  neu     but not   b-raf   
f/f     brain. Subjects were counterstained with hematoxylin. (A) Brain cortex (inset and bottom) and the corresponding quantiﬁ  ca-
tion of positive cells/brain area. The plot shows means   ±   SD; *, P   <   0.02; **, P   <   0.005; and ***, P   <   0.0005 comparing three   b-raf   
f/f     and three   b-raf  
  Δ  /  Δ  neu     
mice. A quantiﬁ  cation of the      IV-tubulin+ cells (premyelinating, early myelinating, and myelinating oligodendrocytes) from the same areas is also shown. 
(B and C)   b-raf  
  Δ  /  Δ  neu     oligodendrocytes fail to differentiate in vitro. Oligodendrocyte precursors from P0   b-raf  
f/f     and   b-raf  
  Δ  /  Δ  neu     pups were allowed to differenti-
ate for 5 (B) or 6 d (C). Differentiation was analyzed by immunoﬂ  uorescence staining with      -NG2,      -O4, and      -MBP antibodies. Examples of single+ and 
double+ cells from a WT culture are shown below in B. In C, cell morphology was visualized by staining with an      -tubulin antibody. The percentage of NG2+ 
cells (oligodendrocyte progenitors), O4+ cells (pro-oligodendrocytes), and MBP+ cells (terminally differentiated oligodendrocytes) present in the   b-raf  
f/f     and 
  b-raf  
  Δ  /  Δ  neu     cultures were compared. Each culture consisted of a pool of two WT or KO mice; for the chemical inhibition of MEK, oligodendrocyte cultures were 
established from pools of four WT mice and kept for 6 d in differentiation medium in the absence (untreated [UT]) or presence of MEK inhibitor (U0126; 10   μ  M). 
In all cases, a minimum of 100 cells/culture were counted independently by two investigators. The experiment was repeated three times, the plots show the 
mean   ±   SD of the results obtained by assessing three separate experiments (*, P   <   0.05 for   b-raf  
f/f     vs.   b-raf  
  Δ  /  Δ  neu    ). Bars, 30   μ  m.     JCB • VOLUME 180 • NUMBER 5 • 2008  952
modular response analysis has recently confi  rmed that ERKs 
negatively feed back on MEKs (  Santos et al., 2007  ). If this were 
true in the developing brain in vivo, less sustained ERK activity 
could explain the stronger MEK phosphorylation. 
  Be that as it may, in postnatal brain development, the 
highest levels of ERK phosphorylation were observed in coinci-
dence with the increased expression of B-Raf and with the onset 
and progress of myelination, which was critically dependent on 
B-Raf. B-Raf  –  defi  cient oligodendrocyte precursors show im-
paired MEK/ERK activation and differentiation in vitro and 
in vivo, and chemical inhibition of MEK prevents the develop-
ment of MBP-expressing cells in WT cultures (  Figs. 4 and 6  ), 
demonstrating a causal relationship between ERK activation 
and terminal oligodendrocyte differentiation. The latter result is 
in agreement with previous reports demonstrating that FGF-
induced ERK activation cooperates with Sonic hedgehog to pro-
mote oligodendrocyte maturation in culture (  Kessaris et al., 
2004  ) and that MEK/ERK inhibition reduces MBP production 
by basal forebrain oligodendrocytes (  Du et al., 2006  ). 
  Thus, in the oligodendrocyte lineage, B-Raf is the critical 
ERK activator. This is underscored by the inability of Raf-1 to 
compensate for B-Raf ablation, notwithstanding its binding to 
MEK in B-Raf  –  defi  cient oligodendrocytes (complex III;   Fig. 6 G  ). 
The molecular basis for this may be simply that the higher in-
trinsic kinase activity of B-Raf is directly required for MEK ac-
tivation in these cells (complex I;   Fig. 6 G  ); alternatively, the 
presence of B-Raf may be required to regulate the kinase activ-
ity of Raf-1 in the context of the recently described B-Raf  –  Raf-1 
heterodimer, which represent the Raf kinase with the highest 
activity (  Garnett et al., 2005  ;   Rushworth et al., 2006  ). In the 
changes in the cellularity and architecture of the nervous sys-
tem itself further implies that, in the context of the whole ani-
mal, B-Raf is not essential for the proliferation or survival of 
neurons. Previous studies have predicted a role for B-Raf in 
neuronal survival (  Wiese et al., 2001  ), differentiation (  Marshall, 
1995  ;   Kao et al., 2001  ), and axon growth (  Markus et al., 2002  ). 
With the caveat that the level of analysis presented in this pa-
per is not suffi  cient to draw conclusions on subtle differences in 
neuronal differentiation, the simplest explanation for the ab-
sence of major defects is that the in vivo environment provides 
a variety of signals that promote neuronal survival and sustains 
differentiation independently of B-Raf, possibly via other Raf 
kinases. In line with this hypothesis, the marginal defects in 
dorsal root ganglia differentiation caused by ablation of   b-raf  
alone become progressively more dramatic when one or both 
  c-raf-1   alleles are eliminated (  Zhong et al., 2007  ). Compound 
  tissue-restricted KOs of the Raf genes will be required to cir-
cumvent redundancy and clarify the biological role of Raf in 
neuronal tissues. 
  In brain lysates, MEK and ERK phosphorylation are not 
synchronized. MEK phosphorylation is highest at early stages 
of postnatal development, when B-Raf is hardly expressed, 
whereas ERK phosphorylation coincides with B-Raf expression 
and is evident at later stages. One trivial but not likely explana-
tion is that MEK and ERK may not be expressed concomitantly 
in the same cell types during early postnatal development. Alter-
natively, if MEK and ERK are expressed concomitantly, the 
discrepancy between MEK and ERK phosphorylation could be 
explained by a stronger negative feedback (e.g., phosphatase 
activity) targeting ERK at these early stages. In PC12 cells, 
  Figure 5.       B-Raf is required for ERK activa-
tion during postnatal brain development.  
(A) Expression/phosphorylation of compo-
nents and targets of the ERK pathway in 
  b-raf   
f/f     (WT) and   b-raf  
  Δ  /  Δ  neu     (KO) brains during 
postnatal development. (right) A quantiﬁ  cation 
of B-Raf, Raf-1, pMEK, and pERK levels from 
at least three animals (mean   ±   SD). Levels are 
expressed as arbitrary units. Variation among 
experiments was minimized by normalizing 
the levels of the proteins of interest to loading 
controls that showed no change over time 
(actin). The dividing line in the      IV-tubulin 
panel indicates that the P18 samples were 
taken from a different gel. (B) Immunohisto-
chemical analysis of ERK phosphorylation in 
B-Raf KO and WT brains. The brown staining 
indicates pERK+ cells. The sections were coun-
terstained with hematoxylin. The vertical bar 
spans the neuropil-rich molecular layer of the 
cerebral cortex. G indicates the granular and 
M the molecular layer of the cerebellar cortex. 
Arrowheads indicate Purkinje cells.     953 B-RAF AND MYELINATION   •   GALABOVA-KOVACS ET AL.
latter case (complex II;   Fig. 6 G  ), the physical presence of B-Raf 
may be more important than its kinase activity (  Garnett et al., 
2005  ). Consistent with the latter hypothesis, mice expressing a 
kinase-dead form of B-Raf do not have a neurological pheno-
type (Pritchard, C., personal communication). 
  In oligodendrocyte-enriched cultures, B-Raf promotes the 
recruitment of KSR1 to the Raf-MEK-ERK module (  Fig. 6 C   
and complex I and II in   Fig. 6 E  ). Currently, KSR is thought to 
bind constitutively to MEK/ERK and present it to Raf, thereby 
both insulating and enhancing ERK signaling. Our data instead 
imply that B-Raf regulates the scaffold function of KSR. It is 
conceivable that B-Raf binds to KSR1 and brings it to the MEK/
ERK module in the context of a B-Raf  –  KSR heterodimer. Alter-
natively, B-Raf may activate KSR, enabling it to bind to MEK1. 
Considering the strong similarity between Raf-1 and KSR, acti-
vation may occur allosterically, in analogy to the recently de-
scribed activation of Raf-1 by B-Raf (  Garnett et al., 2005  ). 
Finally, the association of KSR with the MEK/ERK module 
might be regulated by KSR phosphorylation, mediated directly 
or indirectly by B-Raf. 
  Both soluble and axonal signals could stimulate B-Raf 
activation and oligodendrocyte differentiation in vivo. Candi-
dates are FGF, PDGF, and ErbB receptor ligands, including the 
membrane-tethered neuregulin-1 type III, which has been impli-
cated as a major axonal signal regulating myelination in Schwann 
cells (  Nave and Salzer, 2006  ). Whatever the signals in vivo may 
be, the impaired differentiation observed in   b-raf  
   /  neu     oligo-
dendrocyte cultures suggests that B-Raf is either an essential ef-
fector of the crucial signal or a point of convergence of multiple 
factors promoting oligodendrocyte differentiation. 
  Figure 6.       B-Raf is required for MEK/ERK phos-
phorylation and ERK activation is required for 
differentiation in oligodendrocyte-enriched glial 
cell cultures.   Immunoblot analysis of whole cell 
lysates (40   μ  g) from WT and B-Raf KO oligo-
dendrocyte-enriched (A and C) or oligodendro-
cyte-depleted mixed glial cell cultures (B) left 
untreated or stimulated for 10 min with 100 ng/ml 
PDGF (A and B; 10 min), 20 ng/ml EGF (C), or 
20 ng/ml FGF (C) before lysis. MEK/ERK phos-
phorylation is impaired in oligodendrocyte-
containing but not oligodendrocyte-  depleted 
cultures. In B, the ﬁ  rst lane from the left is slightly 
underloaded. (D) ERK phosphorylation in oligo-
dendrocyte cultures. Cells allowed to differenti-
ate for 2 d and either left untreated or stimulated 
with 20 ng/ml FGF for the indicate times. Cells 
were colabeled with antibodies against pERK 
(green) and pan-tubulin (red). (E) MEK1 immuno-
precipitates were prepared from 400   μ  g WT 
and B-Raf null (KO) oligodendrocyte-enriched 
glial cell cultures, and left untreated or stimu-
lated with 100 ng/ml PDGF (for 10 min) before 
lysis and immunoblotting. C, isotype-matched 
irrelevant Ab control; MEK1 KO, MEK1 ips 
prepared from whole cell lysate of MEK1 KO 
MEFs. (F) ERK phosphorylation in cells of the 
oligodendrocyte lineage in situ. Brain sections 
were colabeled with antibodies against pERK 
(green) and      IV-tubulin (red). Cells were classi-
ﬁ  ed on the basis of their morphology as premy-
elinating oligodendrocytes (left and middle) and 
mature oligodendrocytes (right). Asterisks indi-
cate autoﬂ  uorescent erythrocytes. Bars, 30   μ  m. 
(G) A working model Raf/MEK/ERK complexes 
in differentiating oligodendrocytes. Soluble or 
axonal signals activate the ERK pathway in 
oligodendrocyte precursors. In WT cells, three 
complexes may be formed, two of which are 
B-Raf dependent: complex I, which comprises 
B-Raf, KSR, and MEK/ERK; and complex II, 
which consists of a B-Raf  –  Raf-1 heterodimer 
bound to KSR and MEK/ERK. In complex I, MEK is 
phosphorylated by B-Raf, whereas in complex II, 
the Raf heterodimer is the MEK kinase. Both 
complexes produce a strong, sustained ERK 
signal ultimately leading to oligodendrocyte 
differentiation. Complex III comprises Raf-1 and 
MEK/ERK, is B-Raf independent, and is the only 
complex found in B-Raf  –  deﬁ  cient oligodendro-
cytes. This complex gives rise to a much weaker 
ERK signal, leading to defective oligodendro-
cyte differentiation.     JCB • VOLUME 180 • NUMBER 5 • 2008  954
or unrelated, isotyped-matched controls. Immunocomplexes were visual-
ized using appropriate secondary antibodies conjugated with Alexa 488 
or 594 (Invitrogen), the ultrasensitive avidin biotinylated enzyme complex 
staining kit (ABC; Vector Laboratories), or the EnVision peroxidase system 
(Dako) according to the manufacturer  ’  s instructions, followed by incubation 
with 0.01% diaminobenzidine (Sigma-Aldrich). Epiﬂ  uorescence was per-
formed at room temperature using Immersol 518 (Carl Zeiss, Inc.) as an 
imaging medium and a microscope (Axioplan 2; Carl Zeiss, Inc.) equipped 
with a Plan Neoﬂ  uar 40  ×   1.30 oil objective (Carl Zeiss, Inc.) and a charge-
coupled device (CCD) camera (Spot2; Diagnostic Instruments, Inc.). 
Images were acquired using the MetaVue 5.0r6 software (MDS Analytical 
Technologies). Light microscopy was performed at room temperature using 
Immersol 518 as an imaging medium and a microscope (AxioImager M1) 
equipped with a CCD camera (AxioCam Mrc5; both from Carl Zeiss, Inc.). 
Images were acquired using the Axiovision 4.6 software (Carl Zeiss, Inc.) 
  For transmission electron microscopy, tissue was collected and ﬁ  xed 
in 3% glutaraldehyde in 0.1 M Sorensen phosphate buffer, pH 7.4, at 
4  °  C. After ﬁ  xation, specimens were contrasted with osmium tetraoxide and 
embedded in epoxy resin. Ultrathin sections were cut at 70 nm, stained 
with alkaline-lead citrate and methanolic uranyl acetate, and viewed with 
a transmission electron microscope (EM 900; Carl Zeiss, Inc.). 
  Cell culture 
  Mixed glial cell cultures were obtained from newborn animals (P0), plated 
in NM15 media (DME containing 15% fetal calf serum) for at least 7 d. 
Oligodendrocyte precursors were obtained by differential shaking of 
mixed glial cultures. Immediately after shaking, progenitors were plated on 
poly-  D  -lysine  –  coated dishes in NM15 medium. Differentiation was induced 
24 h later by changing the medium to differentiation medium (DME supple-
mented with 0.5% FCS, 25   μ  g/ml insulin, 5 ng/ml selenium, 50   μ  g/ml 
transferrin, and 20 ng/ml tri-iodothyronine; all from Sigma-Aldrich) and 
was assessed by immunoﬂ  uorescence, staining the cells with      -NG2 (Milli-
pore),      -O4 (R  &  D Systems), and      -MBP (Santa Cruz Biotechnology, Inc.) 
followed by Alexa 488  –   or 594  –  conjugated secondary antibodies (Invitro-
gen). The overall purity of the cultures used in the experiments shown in 
  Figs. 4 and 6   was between 80 and 90%, as assessed by immuno-
ﬂ  uorescence using a combination of antibodies against GFAP, NG2, O4, 
MBP, pan-tubulin, and      IV-tubulin. For biochemistry, oligodendrocyte-
enriched cultures were generated by plating the mixed glial cell cultures in 
differentiation medium supplemented with 10 ng/ml rat recombinant cili-
ary neurotrophic factor for 2 d to allow oligodendrocyte precursors to dif-
ferentiate. Oligodendrocyte-depleted cultures were obtained after repeated 
differential shaking of mixed glial cell cultures to get rid of oligodendrocyte 
precursors and consisted of   >  90% astrocytes. 
  Immunoblot analysis and immunoprecipitation 
  Preparation of brain lysates has been described previously (  Morice et al., 
1999  ). MEK1 immunoprecipitates were prepared using antibodies from 
Transduction Laboratories and washed four times in brain lysate buffer. 
Immunoprecipitates and lysates were subjected to immunoblotting as de-
scribed previously (  Mikula et al., 2001  ). The antibodies used were B-Raf C-19 
(against a C-terminal epitope), H145 (against an N-Terminal epitope), A-Raf 
C-20, actin, MBP (Santa Cruz Biotechnology, Inc.), Raf-1, MEK1, MEK2, 
KSR1, panERK (Transduction Laboratories), pMEK1/2, p44/42 MAPK, 
EGR1 (Cell Signaling Technology),      IV-tubulin, and tubulin (Sigma-Aldrich). 
  Online supplemental material 
  Fig. S1 shows the NestinCre activity pattern in an embryonic day 11.5 
embryo. Figs S2 and S3 show the morphological defects of   b-raf    –  deﬁ  cient 
mouse brain and cerebellum. Fig. S4 shows the myelination defect of 
  b-raf  
  Δ  /  Δ  neu     throughout postnatal development. Fig. S5 shows hypomy-
elination and supernumerary oligodendrocyte precursor in different re-
gions of   b-raf  
  Δ  /  Δ  neu     brains. Videos 1  –  3 show the neurological defects of 
  b-raf  
  Δ  /  Δ  neu     mice. Online supplemental material is available at http://www
.jcb.org/cgi/content/full/jcb.200709069/DC1. 
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  Histological examination shows that ERK phosphoryla-
tion is strongly reduced from P15 on in the brain of   b-raf  
   /  neu    
mice, and we couldn  ’  t identify any specifi  c cell type or location 
that would be spared. With the exception of Purkinje cells, 
pERK staining was seldom associated with the soma of neurons 
but was rather found in smaller cells with heterochromatic nu-
clei characteristic of glia. Specifi  cally, pERK was clearly de-
tectable in premyelinating and myelinating oligodendrocytes of 
WT but not   b-raf  
   /  neu     brains (  Figs. 5 and 6  ). Given the exten-
sive cross-talk between glia and neurons, it is possible that the 
lack of ERK phosphorylation in B-Raf  –  defi  cient neurons may 
not, or not exclusively, be cell autonomous but rather due to the 
lack of support by the oligodendrocytes. It is, for instance, con-
ceivable that the defect may result from the decreased action 
potentials generated as a consequence of delayed/decreased 
myelination. Besides myelination, other oligodendrocyte func-
tions may impact on neurons. Among these are the secretion of 
factors that promote neuronal survival (  Sherman and Brophy, 
2005  ) and the recently reported physical connection between 
NG2+ glial progenitors present in different brain regions with 
surrounding neurons via direct synapses. Particularly relevant 
to the topic of this work, the NG2+ cells of the cerebellum are 
directly innervated by the climbing fi  bers from the inferior olive 
(  Lin et al., 2005  ) and actually share climbing fi  bers with the 
surrounding Purkinje cells. Therefore, they are ideally posi-
tioned to modulate Purkinkje cells excitation by climbing fi  bers 
and cerebellar functions (  Lin et al., 2005  ). 
  The involvement of the macroglia is being increasingly 
  recognized in an expanding number of neurological diseases, in-
cluding Alzheimer  ’  s disease and schizophrenia (  Rowitch, 2004  ; 
 Georgieva et al., 2006 ). We have shown that B-Raf ablation and the 
consequent impairment of ERK activation in oligodendrocytes 
lead to delayed differentiation and dysmyelination and are ulti-
mately incompatible with extrauterine life. With the development 
of safe B-Raf inhibitors for clinical use in mind, it will be important 
to assess whether B-Raf is essential in this lineage during early de-
velopment exclusively or whether its ablation later in life will lead 
to harmful disturbances of the macroglia including demyelination. 
  Materials and methods 
  Mice 
  Generation of mice carrying ﬂ  oxed   b-raf   alleles (  b-raf  
f     
/     
f     ) has been described 
previously (  Chen et al., 2006  ).   b-raf  
f/f     mice were maintained on a 129/Sv 
background and crossed to transgenic mice expressing Cre from the   Mox2   
locus (  Tallquist and Soriano, 2000  ) for epiblast-restricted Raf ablation or to 
transgenic mice expressing Cre under the control of the Nestin promoter 
(  Tronche et al., 1999  ) for neuronal precursor-restricted ablation. Animal care 
was in accordance with the guidelines of the Max F. Perutz Laboratories. 
  PCR analysis of offspring and tissues 
  Tail and tissue DNA preparation and   b-raf   PCR were performed as de-
scribed previously (  Galabova-Kovacs et al., 2006  ). 
  Histology, immunohistochemistry, and electron microscopy 
  Unless stated otherwise, serial sections of 4% paraformaldehyde-ﬁ  xed and 
parafﬁ  n-embedded tissues were cut at 3-  μ  m thickness and placed on pre-
coated slides (0.5% VECTABOND reagent; Vector Laboratories) and rou-
tinely stained with hematoxylin and eosin. 
  The following primary antibodies were used for immunohistochemis-
try:      -pERK (Cell Signaling Technology),      -     IV-tubulin (Sigma-Aldrich), 
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